A Phase I clinical trial at UC San Diego School of Medicine shows that neural stem cell transplantation is safe and feasible for treating chronic spinal cord injuries. Two out of four patients showed significant neurological improvements after treatment.
A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating chronic spinal cord injuries. These devastating injuries often result in partial or full paralysis and are currently incurable.
The study, which followed four patients with chronic spinal cord injuries for five years, found that two patients showed durable evidence of neurological improvement after treatment with neural stem cell implantation, including increased motor and sensory scores, and improved electromyography (EMG) activity. Some patients also showed improvement in pain scores. Neural stem cell transplantation is an emerging treatment for various neurological disorders and injuries that works by implanting human-derived stem cells into damaged or diseased areas of the nervous system. Because these neural stem cells are derived from human cells, this treatment approach has the potential to regenerate damaged tissue while integrating seamlessly into the existing nervous system. The study found that all four patients tolerated the treatment well, and while the current study was only designed to assess safety and tolerability, the results suggest that neural stem cell transplantation may have therapeutic potential for treating chronic spinal cord injuries. Following these promising results, the researchers now hope to initiate a phase II clinical trial to assess the treatment's efficacy
SPINALCORDINJURY NEURALSTEMCELL TREATMENT CLINICALTRIAL CHRONICDISEASE
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphomaLate-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following their initial treatment.
Read more »
Unveiling INST10's role in neural development and cell identityThe Wistar Institute's Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells.
Read more »
Mum’s plea to find stem cell donor for daughter, 9, with deadly blood disorderAmilah Hussein, nine, from Horsham, West Sussex, is in desperate need of a stem cell donor to treat her potentially fatal blood disorder, Aplastic anaemia
Read more »
Tom Curry: England flanker has stem-cell therapy in bid to make 2027 World CupEngland flanker Tom Curry will miss Sale's Champions Cup clash with Racing 92 on Friday for a stem-cell procedure on his chronic hip condition.
Read more »
Tom Curry: England flanker has stem-cell therapy in bid to make 2027 World CupEngland flanker Tom Curry will miss Sale's Champions Cup clash with Racing 92 on Friday for a stem-cell procedure on his chronic hip condition.
Read more »
Push to find lifesaving stem cell match for 'positive and selfless' 21-year-old Telford manA charity has launched an appeal to help find a stem cell match for a 21-year-old from Telford who is battling cancer.
Read more »